UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 626

Sortiert nach

The BRAF-MAPK signaling pathway is essential for cancer-immune evasion in human melanoma cells

The Journal of experimental medicine, 2006-07, Vol.203 (7), p.1651-1656

2006

Volltextzugriff (PDF)

Prognostic Importance of NT-proBNP and Effect of Empagliflozin in the EMPEROR-Reduced Trial

Journal of the American College of Cardiology, 2021-09, Vol.78 (13), p.1321-1332

2021

Volltextzugriff (PDF)

Novel biomarker-driven prognostic models to predict morbidity and mortality in chronic heart failure: the EMPEROR-Reduced trial

European heart journal, 2021-11, Vol.42 (43), p.4455-4464

2021

Volltextzugriff (PDF)

Fibroblast growth factor signaling in development of the cerebral cortex

Development, growth & differentiation, 2009-04, Vol.51 (3), p.299-323

2009

Volltextzugriff (PDF)

Japanese primary care physicians' postpartum mental health care: A cross‐sectional study

Journal of general and family medicine, 2024-07, Vol.25 (4), p.224-231

2024

Volltextzugriff (PDF)

Progress in a selective method for the determination of the acetaldehyde-derived DNA adducts by using HILIC-ESI-MS/MS

Talanta (Oxford), 2018-01, Vol.177, p.12-17

2018

Volltextzugriff (PDF)

Intranasal Immunization with DOTAP Cationic Liposomes Combined with DC-Cholesterol Induces Potent Antigen-Specific Mucosal and Systemic Immune Responses in Mice

PloS one, 2015-10, Vol.10 (10), p.e0139785-e0139785

2015

Volltextzugriff (PDF)

Attachment of class B CpG ODN onto DOTAP/DC-chol liposome in nasal vaccine formulations augments antigen-specific immune responses in mice

BMC research notes, 2017-01, Vol.10 (1), p.68-68, Article 68

2017

Volltextzugriff (PDF)

The mechanisms of cancer immunoescape and development of overcoming strategies

International journal of hematology, 2011-03, Vol.93 (3), p.294-300

2011

Volltextzugriff (PDF)

Simple Pretreatment and HILIC Separation for LC-ESI-MS/MS Determination of Adenosine in Human Plasma

Analytical Sciences, 2015/11/10, Vol.31(11), pp.1189-1192

2015

Volltextzugriff (PDF)

Efficacy of empagliflozin in heart failure with preserved ejection fraction according to frailty status in EMPEROR‐Preserved

Journal of cachexia, sarcopenia and muscle, 2024-02, Vol.15 (1), p.412-424

2024

Volltextzugriff (PDF)

Scaling strategy for cell and gene therapy bioreactors based on turbulent parameters

Biotechnology journal, 2024-01, Vol.19 (1), p.e2300235-n/a

2024

Volltextzugriff (PDF)

Mechanisms of FGFR-mediated carcinogenesis

Biochimica et biophysica acta, 2012-04, Vol.1823 (4), p.850-860

2012

Volltextzugriff (PDF)

Defective Lysosomal Targeting of Activated Fibroblast Growth Factor Receptor 3 in Achondroplasia

Proceedings of the National Academy of Sciences - PNAS, 2004-01, Vol.101 (2), p.609-614

2004

Volltextzugriff (PDF)

Fgf receptor 3 activation promotes selective growth and expansion of occipitotemporal cortex

Neural development, 2009-02, Vol.4 (1), p.4-4, Article 4

2009

Volltextzugriff (PDF)

K-Ras and β-catenin mutations cooperate with Fgfr3 mutations in mice to promote tumorigenesis in the skin and lung, but not in the bladder

Disease models & mechanisms, 2011-07, Vol.4 (4), p.548-555

2011

Volltextzugriff (PDF)

Mitogen-inducible gene 6 is an endogenous inhibitor of HGF/Met-induced cell migration and neurite growth

The Journal of cell biology, 2005-10, Vol.171 (2), p.337-348

2005

Volltextzugriff (PDF)

Fgfr3 regulates development of the caudal telencephalon

Developmental dynamics, 2011-06, Vol.240 (6), p.1586-1599

2011

Volltextzugriff (PDF)

FGFR3 regulates brain size by controlling progenitor cell proliferation and apoptosis during embryonic development

Developmental biology, 2005-03, Vol.279 (1), p.73-85

2005

Volltextzugriff (PDF)

Empagliflozin in Patients With Heart Failure, Reduced Ejection Fraction, and Volume Overload

Journal of the American College of Cardiology, 2021-03, Vol.77 (11), p.1381-1392

2021

Volltextzugriff (PDF)

Empagliflozin in Patients With Heart Failure, Reduced Ejection Fraction, and Volume Overload: EMPEROR-Reduced Trial

Journal of the American College of Cardiology, 2021-03, Vol.77 (11), p.1381-1392

2021

Volltextzugriff (PDF)

Regulation of cell proliferation and apoptosis in neuroblastoma cells by ccp1, a FGF2 downstream gene

BMC cancer, 2010-11, Vol.10 (1), p.657-657, Article 657

2010

Volltextzugriff (PDF)

Influence of neprilysin inhibition on the efficacy and safety of empagliflozin in patients with chronic heart failure and a reduced ejection fraction: the EMPEROR-Reduced trial

European heart journal, 2021-02, Vol.42 (6), p.671-680

2021

Volltextzugriff (PDF)

Impact of anaemia and the effect of empagliflozin in heart failure with reduced ejection fraction: findings from EMPEROR‐Reduced

European journal of heart failure, 2022-04, Vol.24 (4), p.708-715

2022

Volltextzugriff (PDF)

Improvement of cancer immunotherapy by combining molecular targeted therapy

Frontiers in oncology, 2013-01, Vol.3, p.136-136

2013

Volltextzugriff (PDF)

1 – 25 von 626

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(511)
Mit Volltextzugriff
(589)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

The BRAF-MAPK signaling pathway is essential for cancer-immune evasion in human melanoma cells

Prognostic Importance of NT-proBNP and Effect of Empagliflozin in the EMPEROR-Reduced Trial

Novel biomarker-driven prognostic models to predict morbidity and mortality in chronic heart failure: the EMPEROR-Reduced trial

Fibroblast growth factor signaling in development of the cerebral cortex

Japanese primary care physicians' postpartum mental health care: A cross‐sectional study

Progress in a selective method for the determination of the acetaldehyde-derived DNA adducts by using HILIC-ESI-MS/MS

Intranasal Immunization with DOTAP Cationic Liposomes Combined with DC-Cholesterol Induces Potent Antigen-Specific Mucosal and Systemic Immune Responses in Mice

Attachment of class B CpG ODN onto DOTAP/DC-chol liposome in nasal vaccine formulations augments antigen-specific immune responses in mice

The mechanisms of cancer immunoescape and development of overcoming strategies

Simple Pretreatment and HILIC Separation for LC-ESI-MS/MS Determination of Adenosine in Human Plasma

Efficacy of empagliflozin in heart failure with preserved ejection fraction according to frailty status in EMPEROR‐Preserved

Scaling strategy for cell and gene therapy bioreactors based on turbulent parameters

Mechanisms of FGFR-mediated carcinogenesis

Defective Lysosomal Targeting of Activated Fibroblast Growth Factor Receptor 3 in Achondroplasia

Fgf receptor 3 activation promotes selective growth and expansion of occipitotemporal cortex

K-Ras and β-catenin mutations cooperate with Fgfr3 mutations in mice to promote tumorigenesis in the skin and lung, but not in the bladder

Mitogen-inducible gene 6 is an endogenous inhibitor of HGF/Met-induced cell migration and neurite growth

Fgfr3 regulates development of the caudal telencephalon

FGFR3 regulates brain size by controlling progenitor cell proliferation and apoptosis during embryonic development

Empagliflozin in Patients With Heart Failure, Reduced Ejection Fraction, and Volume Overload

Empagliflozin in Patients With Heart Failure, Reduced Ejection Fraction, and Volume Overload: EMPEROR-Reduced Trial

Regulation of cell proliferation and apoptosis in neuroblastoma cells by ccp1, a FGF2 downstream gene

Influence of neprilysin inhibition on the efficacy and safety of empagliflozin in patients with chronic heart failure and a reduced ejection fraction: the EMPEROR-Reduced trial

Impact of anaemia and the effect of empagliflozin in heart failure with reduced ejection fraction: findings from EMPEROR‐Reduced

Improvement of cancer immunotherapy by combining molecular targeted therapy

Suchergebnisse filtern